BD's Q2 Revenues Drop Slightly While Biosciences Biz Rises 3 Percent

BD Biosciences saw its second-quarter revenues rise 3 percent, while overall BD's revenues were down slightly.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.